BDX

碧迪
NYSE

实时行情|Nasdaq Last Sale

251.37
+13.82
+5.82%
交易中 15:54 04/08 EDT
开盘
239.41
昨收
237.55
最高
251.63
最低
235.32
成交量
175.34万
成交额
--
52周最高
286.72
52周最低
197.75
市值
681.65亿
市盈率(TTM)
104.95
分时
5日
1月
3月
1年
5年

分析师评级

17位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测BDX价格均价为268.77,最高价位290.00,最低价为234.00。

EPS

BDX 新闻

更多
  • SVB Leerink Maintains Market Perform on Becton, Dickinson, Lowers Price Target to $245
  • Benzinga · 4小时前
  • Wells Fargo Maintains Overweight on Becton, Dickinson, Lowers Price Target to $270
  • Benzinga · 7小时前
  • FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AAN, BDX, FLR and INO
  • GlobeNewswire · 16小时前
  • SHAREHOLDER ALERT: BDX TUFN ANAB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
  • ACCESSWIRE · 21小时前

所属板块

医疗设备、用品及经销
+5.88%
医疗设备和用品
+4.97%

热门股票

代码
价格
涨跌幅

BDX 简况

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.
展开

微牛提供Becton Dickinson and Co(NYSE-BDX)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的BDX股票新闻,以帮助您做出投资决策。